| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 1.55 Billion | USD 5.71 Billion | 15.6% | 2024 |
FrequentlyAsked Questions
The global single-use bioreactors market is expected to grow due to growing adoption of cost-effective and flexible bioprocessing solutions, increasing demand for biopharmaceuticals, advancements in disposable technologies, and rising biopharmaceutical R&D investments.
According to a study, the global single-use bioreactors market size was worth around USD 1.55 Billion in 2024 and is expected to reach USD 5.71 Billion by 2034.
The global single-use bioreactors market is expected to grow at a CAGR of 15.6% during the forecast period.
North America is expected to dominate the single-use bioreactors market over the forecast period.
Leading players in the global single-use bioreactors market include Thermo Fisher Scientific, Danaher Corporation, Merck KGaA, Getinge AB, Eppendorf AG, CESCO Bioengineering, Cellexus, PBS Biotech Inc, Distek Inc, ABEC, Able Corporation & Biott Corporation, G&G Technologies Inc, Solida Biotech GmBH, Stobbe Pharma, Celltainer Biotech BV, Meissner Filtration Products Inc., bbi-biotech GmBH, ENDEL ENGIE (France), OmniBRx biotechnologies, New Horizon Biotechnology Inc, Satake Chemical Equipment Mfg., Ltd, Sartorius Stedim Biotech, GPC Bio, Cell culture company, Aptus bioreactors, among others.
The report explores crucial aspects of the single-use bioreactors market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients